Naruemol Ekpoom
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Journal: Frontiers in immunology
Published: November 04, 2022
CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Journal: Frontiers in immunology
Published: May 28, 2021
Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients.
Journal: Immunity, inflammation and disease
Published: March 26, 2021
Circulating NKG2A-NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients.
Journal: Annals of transplantation
Published: December 22, 2020
Patients with idiopathic recurrent miscarriage have abnormally high TGFß+ blood NK, NKT and T cells in the presence of abnormally low TGFß plasma levels.
Journal: BMC immunology
Published: January 22, 2019
Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant.
Journal: Clinical and experimental immunology
Published: April 13, 2018
Changes of NK cell subsets with time post-transplant in peripheral blood of renal transplant recipients.
Journal: Transplant immunology
Published: February 07, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026